147065
Use of Murphy-Pierrot Procedure in Treatment of Pediatric Neurologic Equinus Deformities
Tuesday, November 6, 2007: 12:30 PM
Use of Murphy-Pierrot Procedure in Treatment of Pediatric Neurologic Equinus Deformities Uncompensated Neurospastic Equinus is a deformity which is commonly seen among children born with Cerebral Palsy. This neurological complication becomes a vital delimiter of a child's capacity for independent ambulation. As such, the deformity carries with it both physical and social infirmities, which significantly affect productivity and quality of life. Over the last 10 years, outcomes have been tracked in pediatric patients (aged 2 years to 17 years) presenting with this disabling physical impairment, seen through the Yucatan Crippled Children's Project. Treatment on the majority of these patients has consisted of a Murphy-Pierrot Tendo Achilles tendon transfer procedure, which appears to have effectively brought the heel to the ground with a retained positional reduction in contrast to Tendo-Achilles lengthening procedures, which have uniformly resulted in recurrence of the deformity over time. Favorable outcomes have been evaluated and can be associated directly with increasing individual productivity and social enhancement.
Learning Objectives: 1. Explain why Neurologic Equinus is a common deformity seen in Children born with Cerebral Palsy.
2. Detail the adverse consequences untreated neurologic equinus may have on an individual's developmental and social opportunities.
3. Review historical treatments for Equinus, both non-invasive as well as invasive
4. Explain why an Achilles Tendon Transposition is preferable to a Tendo-Achilles Lengthening for long term resolution
5. Demonstrate the numbers of redos necessary on patients who have undergone Tendo-Achilles Lengthenings, compared with transpositional surgery.
6. Contrast our outcomes with other studies, which have been reported on similar procedures
Keywords: Children With Special Needs, Infant Health
Presenting author's disclosure statement:Any relevant financial relationships? No Any institutionally-contracted trials related to this submission?
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.
|